Barclays PLC Mimedx Group, Inc. Transaction History
Barclays PLC
- $436 Billion
- Q2 2025
A detailed history of Barclays PLC transactions in Mimedx Group, Inc. stock. As of the latest transaction made, Barclays PLC holds 407,721 shares of MDXG stock, worth $3.01 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
407,721
              Previous 407,721
              
        
           -0.0%
        
      
          
        Holding current value
$3.01 Million
            Previous $2.49 Million
            
        
           -0.0%
        
      
          
        % of portfolio
0.0%
            Previous 0.0%
          
        Shares
	  18 transactions
	
  Others Institutions Holding MDXG
# of Institutions
246Shares Held
102MCall Options Held
51.2KPut Options Held
56.8K- 
    
      Essex Woodlands Management, Inc. The Woodlands, TX28.2MShares$208 Million61.77% of portfolio
- 
    
      Black Rock Inc. New York, NY9.31MShares$68.7 Million0.0% of portfolio
- 
    
      Trigran Investments, Inc.8.39MShares$61.9 Million9.54% of portfolio
- 
    
      Vanguard Group Inc Valley Forge, PA6.96MShares$51.3 Million0.0% of portfolio
- 
    
      Paradigm Capital Management Inc4.45MShares$32.9 Million1.34% of portfolio
About MIMEDX GROUP, INC.
- Ticker MDXG
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 113,609,000
- Market Cap $838M
- Description
- MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins. The company's patented and proprietary pr...